Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2005
11/17/2005US20050255447 Made of processed blood cells for simulating human immature granulocytes and a suitable suspension medium; impedance, light scatter and axial light loss measurements
11/17/2005US20050255446 Perfusion system and apparatus for automated multi-channel patch-clamp recordings utilizing inside-out whole-cell configuration
11/17/2005US20050255445 Method for high throughput cell-based assays using versatile living microarrays
11/17/2005US20050255444 Method for detecting arcenic iIons with iIndicator bacteria
11/17/2005US20050255125 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
11/17/2005US20050255124 HCV E1E2 vaccine compositions
11/17/2005US20050255123 Chimeric ebola virus envelopes and uses therefor
11/17/2005US20050255120 Composition and method for introduction of DNA directed RNA interference sequences into targeted cells and tissues
11/17/2005US20050255114 Methods and diagnosis for the treatment of preeclampsia
11/17/2005US20050255102 binds to alpha v beta 6 and not other alpha v integrins or non-specific integrins; inhibits the binding of alpha v beta 6 to latency associated peptide with an IC50 value lower than that of 10D5 and binds alpha v beta 6 in manner that does not distinguish between the use of Ca2+/Mg2+ and Mn2+ for cation
11/17/2005US20050255101 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
11/17/2005US20050255090 High enzyme activity; screening its relative symbiotic bacteria using a specific antibody
11/17/2005US20050255089 adeno-associated virus 5 (AAV5) specific polynucleotides, that codes for an AAV5 specific proteins; delivering polynucleotides to cells using the AAV5 vectors and particles
11/17/2005US20050255043 Bacteriophage imaging of inflammation
11/17/2005US20050253403 Collision energy-absorbing device
11/17/2005US20050252769 Electric-current biosensor
11/17/2005DE10393431T5 Mikroarrays mit mehreren Oligonukleotiden in einzelnen Array Features Microarrays with multiple oligonucleotides in each array features
11/17/2005DE102004022350A1 Diagnose von Infektionserkrankungen Diagnosis of infectious diseases
11/17/2005DE102004021822B3 Verfahren und Anordnung zur DNA-Amplifikation mittels PCR unter Einsatz von Trockenreagenzien Method and system for DNA amplification by PCR using dry reagents
11/17/2005DE10157070B4 Anordnung zur Messung von durch Ionenkanäle fließenden Ionenströmen, sowie Verfahren zur Herstellung dieser und Messverfahren Arrangement for measuring ionic currents flowing through ion channels, as well as methods for preparing these and measurement methods
11/17/2005DE10050942B4 Verfahren zum Nachweis von Cytosin-Methylierungen A method for the detection of cytosine methylations
11/17/2005CA2569085A1 Polynucleotides for the detection of escherichia coli
11/17/2005CA2569083A1 Detecting disease association with aberrant glycogen synthase kinase 3.beta. expression
11/17/2005CA2566423A1 Novel hiv-based recombinant viral clones and use thereof in analytical methods
11/17/2005CA2566418A1 Polynucleotides for the detection of staphylococcus aureus
11/17/2005CA2566041A1 T-type calcium channel splice variant compositions and methods
11/17/2005CA2565858A1 Assay for drug discovery based on in vitro differentiated cells
11/17/2005CA2565855A1 Patterned cell network substrate interface and methods and uses thereof
11/17/2005CA2565679A1 Device and method for detecting molecular interactions
11/17/2005CA2565676A1 Gm3 synthase as a therapeutic target in microvascular complications of diabetes
11/17/2005CA2565572A1 A microfluidic device and methods for processing polynucleotide-containing samples
11/17/2005CA2565566A1 Use of il-17 expression to predict skin inflammation; methods of treatment
11/17/2005CA2565562A1 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
11/17/2005CA2565043A1 Methods of treating demyelinating disorders
11/17/2005CA2564850A1 Mn/ca ix/ ca9 and renal cancer prognosis
11/17/2005CA2564837A1 Internal control in situ hybridization
11/17/2005CA2564769A1 Cellular permissivity factor for viruses, and uses thereof
11/17/2005CA2564484A1 Senp1 as a marker for cancer
11/17/2005CA2563521A1 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005CA2563510A1 Method for preparing substrates having immobilized molecules and substrates
11/17/2005CA2563394A1 Method of examining the functional genic variability of hiv and kit for implementing same
11/17/2005CA2563367A1 Novel compositions and methods in cancer
11/17/2005CA2563168A1 Nucleic-acid programmable protein arrays
11/17/2005CA2562310A1 Methods and compositions for cancer diagnosis
11/17/2005CA2561901A1 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
11/17/2005CA2560865A1 Cancer associated antigens
11/17/2005CA2560264A1 Gm1 promoter and use thereof
11/17/2005CA2547933A1 Secreted insecticidal protein and gene compositions from bacillus thuringiensis and uses therefor
11/16/2005EP1596190A1 Sensor
11/16/2005EP1595962A2 Methods for in situ generation of nucleic acid arrays
11/16/2005EP1595961A1 Methods for in situ generation of nucleic acid arrays
11/16/2005EP1595960A1 DNA detection via complex of reassociated strings
11/16/2005EP1595959A1 Method for enhancing efficacy of preparation of monoclonal antibody
11/16/2005EP1595958A1 Staphylococcus aureus specific array and diagnostics
11/16/2005EP1595957A1 Phosphoglycerate mutases and enzyme products
11/16/2005EP1595953A1 Signal amplification method for detecting mutant gene
11/16/2005EP1595952A1 Method of estimating antitumor effect of histone deacetylase inhibitor
11/16/2005EP1595950A1 Method of measuring homocysteine
11/16/2005EP1595945A1 Screening method for identifying compounds that have the ability to inhibit the activity of Myc
11/16/2005EP1595890A2 Synthetic peptide inhibitors of HIV transmission
11/16/2005EP1595145A2 Methods for the treatment of renal cell carcinoma
11/16/2005EP1595144A1 Microarray devices having controllable reaction volume
11/16/2005EP1595129A2 Methods of identifying modulators of cellular glycosylation using gtrap3-18
11/16/2005EP1595127A2 Chip-in-a-well scanning
11/16/2005EP1595120A1 Metal coated nanocrystalline silicon as an active surface enhanced raman spectroscopy (sers) substrate
11/16/2005EP1594992A2 Comositions and methods for screening using populations of surrogate antibodies
11/16/2005EP1594991A1 Method of producing recombinant dna molecules
11/16/2005EP1594990A2 Method of monitoring genomic instability using 3d microscopy and analysis
11/16/2005EP1594989A2 Methods for the early diagnosis of ovarian cancer
11/16/2005EP1594988A2 Method of diagnosis of type 2 diabetes and early onset thereof
11/16/2005EP1594987A2 Nucleic acid sequencing methods, kits and reagents
11/16/2005EP1594986A2 Use of a gene mutation in the human gnas gene for predicting risks of diseases, courses of the disease and for predicting the response to disease therapies
11/16/2005EP1594985A1 Method for determining susceptibility to schizophrenia
11/16/2005EP1594984A2 Compositions and methods for multiplex analysis of polynucleotides
11/16/2005EP1594983A2 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome
11/16/2005EP1594982A2 Methods and compositions for rna detection and quantitation
11/16/2005EP1594981A2 Double ended sequencing
11/16/2005EP1594980A2 Bead emulsion nucleic acid amplification
11/16/2005EP1594979A2 Nanocylinder-modified surfaces
11/16/2005EP1594978A2 Assay for the identification of protein sic inhibitors
11/16/2005EP1594977A2 Reversible attachment of a membrane active polymer to a polynucleotide
11/16/2005EP1594975A2 Multiplex amplification of polynucleotides
11/16/2005EP1594964A2 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor
11/16/2005EP1594962A2 Covalent tethering of functional groups to proteins
11/16/2005EP1594950A2 Method for preparing single-stranded dna libraries
11/16/2005EP1594900A2 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers
11/16/2005EP1594893A2 Therapeutic targets in cancer
11/16/2005EP1594892A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
11/16/2005EP1594881A1 Concurrent microorganism identification and susceptibilities from broth
11/16/2005EP1594855A2 Signalling compounds for use in methods of detecting hydrogen peroxide
11/16/2005EP1594694A2 Methods and apparatus for pathogen detection and analysis
11/16/2005EP1594539A2 Compositions for modulating immune cell activity and methods for detection thereof
11/16/2005EP1594485A2 Compositions containing substituted quinolines and substituted diphenyl sulfones and methods of use
11/16/2005EP1594446A2 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING
11/16/2005EP1594442A2 Knockout identification of target-specific sites in peptides
11/16/2005EP1594435A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/16/2005EP1594433A2 Cancer therapy sensitizer
11/16/2005EP1532445A4 Method for the identification of ligands
11/16/2005EP1490768A4 Adaptive behavioral intrusion detection systems and methods
11/16/2005EP1490499A4 Nucleic acid detection method
1 ... 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 ... 3003